Table 4.
Multivariate linear regression analysis to evaluate the relation between severity of disease parameters and treatment and critical evolution outcomes (45 events)
| Variable | OR estimate (95% CI) | P-value |
|---|---|---|
| Model 1 | ||
| Age | 1.002 (0.965–1.043) | 0.90 |
| Oxygen therapy on diagnosis | 3.281 (1.396–7.97) | 0.007 |
| Lymphocytes | 0.186 (0.057–0.530) | 0.003 |
| CRP | 1.006 (1.001–1.013) | 0.02 |
| AZT/HCQ combination | 0.475 (0.188–1.116) | 0.11 |
| Model 2 | ||
| Age | 1.012 (0.980–1.048) | 0.46 |
| Congestive heart failure (LVEF <45%) | 1.665 (0.452–6.481) | 0.44 |
| Atrial fibrillation | 1.838 (0.751–4.481) | 0.13 |
| Peripheral vascular disease | 2.192 (0.884–5.554) | 0.15 |
| ARBs (current medication) | 0.342 (0.085–1.110) | 0.08 |
LVEF, left ventricular ejection fraction.